First reported at 2,361 shares this quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2023-09-30 | 5821 |
| 2023-12-31 | 105532 |
| 2024-03-31 | 129763 |
| 2024-06-30 | 10885 |
| 2024-09-30 | 5232 |
| 2024-12-31 | 0 |
| 2025-03-31 | 13033 |
| 2025-06-30 | 306987 |
| 2025-09-30 | 83593 |
| 2025-12-31 | 2549481 |
| 2026-03-31 | 1575636 |
| 2026-06-30 | 1828255 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2026 | Added | 401,814 | +7,905 (2.0%) | < 0.01% | $1,828,255 | 2026-08-13 | |
| Q1 2026 | Added | 393,909 | +28,654 (7.8%) | < 0.01% | $1,575,636 | 2026-05-15 | |
| Q4 2025 | Added | 365,255 | +347,278 (1931.8%) | < 0.01% | $2,549,481 | 2026-02-13 | |
| Q3 2025 | Reduced | 17,977 | -38,351 (-68.1%) | < 0.01% | $83,593 | 2025-11-14 | |
| Q2 2025 | Added | 56,328 | +53,967 (2285.8%) | < 0.01% | $306,987 | 2025-08-15 | |
| Q1 2025 | New | 2,361 | +2,361 (0.0%) | < 0.01% | $13,033 | 2025-05-15 | |
| Q4 2024 | Reduced | 0 | -1,135 (-100.0%) | 0 | $0 | 2025-02-14 | |
| Q3 2024 | Reduced | 1,135 | -837 (-42.4%) | < 0.01% | $5,232 | 2024-11-14 | |
| Q2 2024 | Reduced | 1,972 | -11,337 (-85.2%) | < 0.01% | $10,885 | 2024-08-14 | |
| Q1 2024 | Added | 13,309 | +820 (6.6%) | < 0.01% | $129,763 | 2024-05-15 | |
| Q4 2023 | Added | 12,489 | +11,352 (998.4%) | < 0.01% | $105,532 | 2024-02-13 | |
| Q3 2023 | New | 1,137 | +1,137 (0.0%) | < 0.01% | $5,821 | 2023-11-15 |
Who else reported the position
41 managers reported TRISALUS LIFE SCIENCES INC for Q1 2025.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| GILDER GAGNON HOWE & CO LLC | Added | 827,357 | +812,937 | 0.06% | $4,567,011 | 3 qtrs |
| Wealthcare Advisory Partners LLC | Unchanged | 643,740 | 0 | 0.1% | $3,553,445 | 3 qtrs |
| VANGUARD GROUP INC | Added | 486,618 | +10,326 | < 0.01% | $2,686,132 | 6 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 219,424 | +15,287 | < 0.01% | $1,211,554 | 7 qtrs |
| Bank of America Corporation | Added | 185,532 | +7,086 | < 0.01% | $1,024,137 | 5 qtrs |
| MILLENNIUM MANAGEMENT LLC | Added | 133,380 | +52,842 | < 0.01% | $736,258 | 5 qtrs |
| BRIDGEWAY CAPITAL MANAGEMENT LLC | Unchanged | 65,000 | 0 | < 0.01% | $358,800 | 3 qtrs |
| MSD Partners L P | Unchanged | 39,999 | 0 | 0.16% | $220,794 | 3 qtrs |
| NORTHERN TRUST CORPORATION | Added | 39,926 | +7,814 | < 0.01% | $220,392 | 6 qtrs |
| The Goldman Sachs Group Inc | New | 33,900 | +33,900 | < 0.01% | $187,128 | 1 qtr |
Filing details and methodology As reported
- Report period
- March 31, 2025
- Filed
- May 15, 2025
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 1,002
- Shared
- 0
- None
- 1,359
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.